AEterna Zentaris (AEZS)
(Delayed Data from NSDQ)
$8.16 USD
-0.43 (-5.01%)
Updated Jun 4, 2024 02:17 PM ET
After-Market: $7.92 -0.24 (-2.94%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
AEterna Zentaris Inc. [AEZS]
Reports for Purchase
Showing records 81 - 100 ( 168 total )
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
We are placing Aeterna Zentaris under review due to the departure of the covering analyst
Provider: RODMAN & RENSHAW, CO.
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
1Q12 UPDATE - MULTIPLE MYELOMA TRIAL MOVES FORWARD - PIPELINE PROMISING
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
1Q12 UPDATE - MULTIPLE MYELOMA TRIAL MOVES FORWARD - PIPELINE PROMISING
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
Perifosine Fails - Late-stage Pipeline Holds Potential - Time Will Tell - Lowering Rating
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
Perifosine Fails - Late-stage Pipeline Holds Potential - Time Will Tell - Lowering Rating
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
4Q11 UPDATE SIGNIFICANT ADVANCES ACHIEVED - PERIFOSINE PHASE 3 DATA IN 2Q12.
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
4Q11 UPDATE SIGNIFICANT ADVANCES ACHIEVED - PERIFOSINE PHASE 3 DATA IN 2Q12.
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
LIVE FROM FRANKFURT! - THE ZENTARIS JUGGERNAUT FORGES NOVEL THERAPEUTICS
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
LIVE FROM FRANKFURT! - THE ZENTARIS JUGGERNAUT FORGES NOVEL THERAPEUTICS
Provider: RODMAN & RENSHAW, CO.
Analyst: BENJAMIN R
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.
Company: AEterna Zentaris Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: RODMAN & RENSHAW, CO.